Beta Bionics, Inc. (BBNX) vs Bioventus Inc. (BVS)
A side-by-side comparison of Beta Bionics, Inc. and Bioventus Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BBNX
Beta Bionics, Inc.
$18.63HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
BVS
Bioventus Inc.
$13.10HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BBNX vs BVS
growth of $100 · dividends reinvested · last 2yBBNX -19.8% (-10.4%/yr)BVS +26.9% (+12.7%/yr)BVS compounded faster over this window
BBNX BVS
BBNX vs BVS: by the numbers
- •BVS is the larger company ($887M vs $838M market cap).
- •BVS is profitable (9.36% net margin) while BBNX runs a net loss (-61.32%).
Metrics side by side
Valuation
| Metric | BBNX | BVS |
|---|---|---|
| P/E ratio | N/A | 17.01 |
| Forward P/E | N/A | 16.82 |
| P/S ratio | 7.04 | 1.53 |
| P/B ratio | 3.27 | 3.89 |
| EV / EBITDA | N/A | 10.48 |
| FCF yield | N/A | 10.62% |
Profitability
| Metric | BBNX | BVS |
|---|---|---|
| Gross margin | 58.31% | 68.00% |
| Operating margin | -69.75% | 10.63% |
| Net margin | -61.32% | 9.36% |
| ROE | -28.46% | 23.86% |
| ROIC | -31.17% | 11.37% |
Growth (annualized)
| Metric | BBNX | BVS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 11.82% |
| EPS CAGR (5Y) | N/A | -5.03% |
| FCF CAGR (5Y) | N/A | 43.36% |
| Total return CAGR (5Y) | N/A | -0.81% |
Frequently asked
- Is BBNX or BVS more profitable?
- BVS runs the higher net margin — BBNX at -61.32% versus BVS at 9.36%.
Go deeper
Dig into the metrics
Bioventus P/E ratioBeta Bionics ROEBioventus ROEBeta Bionics operating marginBioventus operating marginBeta Bionics revenue growthBioventus revenue growthBeta Bionics free cash flowBioventus free cash flow
Beta Bionics & Bioventus appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.